JP2008532951A5 - - Google Patents

Download PDF

Info

Publication number
JP2008532951A5
JP2008532951A5 JP2008500009A JP2008500009A JP2008532951A5 JP 2008532951 A5 JP2008532951 A5 JP 2008532951A5 JP 2008500009 A JP2008500009 A JP 2008500009A JP 2008500009 A JP2008500009 A JP 2008500009A JP 2008532951 A5 JP2008532951 A5 JP 2008532951A5
Authority
JP
Japan
Prior art keywords
delaying
atherosclerosis
progression
administering
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008500009A
Other languages
English (en)
Other versions
JP2008532951A (ja
JP5380069B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2006/000314 external-priority patent/WO2006094357A1/en
Publication of JP2008532951A publication Critical patent/JP2008532951A/ja
Publication of JP2008532951A5 publication Critical patent/JP2008532951A5/ja
Application granted granted Critical
Publication of JP5380069B2 publication Critical patent/JP5380069B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

他の態様において、本発明は、被検体におけるアテローム性動脈硬化および/または冠状動脈性心疾患の発症を予防、遅延させ、および/またはその進行を遅らせる方法であって、以上に規定されている少なくとも1つの化合物の有効量を投与することを含む方法を提供する。
JP2008500009A 2005-03-11 2006-03-10 フラボノイド化合物およびその使用 Expired - Fee Related JP5380069B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2005901214A AU2005901214A0 (en) 2005-03-11 Flavonoid compounds and uses thereof
AU2005901214 2005-03-11
PCT/AU2006/000314 WO2006094357A1 (en) 2005-03-11 2006-03-10 Flavonoid compounds and uses thereof

Publications (3)

Publication Number Publication Date
JP2008532951A JP2008532951A (ja) 2008-08-21
JP2008532951A5 true JP2008532951A5 (ja) 2012-11-22
JP5380069B2 JP5380069B2 (ja) 2014-01-08

Family

ID=36952879

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008500009A Expired - Fee Related JP5380069B2 (ja) 2005-03-11 2006-03-10 フラボノイド化合物およびその使用

Country Status (15)

Country Link
US (1) US8017649B2 (ja)
EP (1) EP1856085B1 (ja)
JP (1) JP5380069B2 (ja)
KR (1) KR101397510B1 (ja)
CN (1) CN101137639B (ja)
AU (1) AU2006222556B2 (ja)
BR (1) BRPI0608402B8 (ja)
CA (1) CA2601028C (ja)
DK (1) DK1856085T3 (ja)
ES (1) ES2552108T3 (ja)
NZ (1) NZ560633A (ja)
RU (1) RU2431634C2 (ja)
SG (1) SG162773A1 (ja)
WO (1) WO2006094357A1 (ja)
ZA (1) ZA200707427B (ja)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ560633A (en) 2005-03-11 2011-08-26 Neuprotect Pty Ltd Flavonoid compounds and uses thereof
AU2006233256B2 (en) * 2006-10-30 2012-01-19 Armaron Bio Pty Ltd Improved flavonols
JP2010514790A (ja) * 2006-12-28 2010-05-06 リメリック バイオファーマ， インコーポレイテッド 治療処置のための方法および組成物
KR100930467B1 (ko) * 2007-06-07 2009-12-08 동아제약주식회사 점액분비를 촉진시키는 3',4',5-트리메톡시 플라본 유도체화합물, 그의 제조방법 및 약학적 용도
US20090258939A1 (en) * 2007-07-31 2009-10-15 Wendye Robbins Pyrone analog compositions and methods
MX2010001141A (es) * 2007-07-31 2010-03-01 Limerick Biopharma Inc Analogos fosforiladosde pirona y metodos.
WO2009018326A2 (en) * 2007-07-31 2009-02-05 Limerick Biopharma, Inc. Soluble pyrone analogs methods and compositions
US8034838B2 (en) * 2008-05-29 2011-10-11 Daryl Lee Thompson Composition and method for the treatment of neurological disorders
WO2010042886A2 (en) * 2008-10-10 2010-04-15 Limerick Biopharma, Inc. Pyrone analogs for therapeutic treatment
KR101586992B1 (ko) * 2009-03-20 2016-01-20 건국대학교 산학협력단 플라보노이드를 유효성분으로 하는 배아 발생 개선용 조성물 및 그 방법
WO2011013735A1 (ja) * 2009-07-31 2011-02-03 国立大学法人 岡山大学 新規フラバノン誘導体
EP2598138B1 (en) 2010-07-27 2020-05-06 Trustees of Boston University Aryl hydrocarbon receptor (ahr) modifiers as novel cancer therapeutics
CN102464642B (zh) * 2010-11-18 2014-04-23 谢联金 一种化合物及其制备方法及其作为饲料添加剂的应用
KR101459712B1 (ko) * 2012-09-10 2014-11-12 건국대학교 산학협력단 야누스 키나아제 3을 활성을 선택적으로 저해하는 플라보노이드 유도체
ES2730926T3 (es) * 2012-10-11 2019-11-13 Armaron Bio Pty Ltd Nuevos compuestos flavonoides y usos de los mismos
CN102861053B (zh) * 2012-10-27 2013-07-10 南京大学 Houttuynoid D在治疗白血病药物中的应用
CN104592246A (zh) * 2013-10-30 2015-05-06 周亚伟 一种黄酮类化合物及其制备方法和应用
US9260461B2 (en) * 2014-02-03 2016-02-16 Versitech Limited Water-soluble derivatives and prodrugs of acacetin and methods of making and using thereof
CA2953387C (en) * 2014-06-30 2023-11-28 The Regents Of The University Of California Ketobutyrate compounds and compositions for treating age-related symptoms and diseases
CN104387360B (zh) * 2014-11-21 2016-10-05 潍坊医学院 柚皮素脂肪酸酯、其制备方法和以该化合物为活性成分的药物组合物及其应用
US10123991B2 (en) 2015-05-15 2018-11-13 Global Biolife Inc. Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders
CN105153093B (zh) * 2015-08-29 2017-07-21 西南民族大学 一种黄酮类化合物及其制备方法和用途
CN105153254B (zh) * 2015-08-29 2018-03-30 西南民族大学 一种黄酮类化合物
CN106632479B (zh) * 2016-12-22 2018-10-23 贵州大学 O,o’-二烷基-o”-(取代黄酮-3-基)磷酸酯类衍生物、制备方法及应用
WO2019005829A1 (en) * 2017-06-26 2019-01-03 Wayne State University METHODS AND COMPOSITIONS RELATING TO CANCER DEPENDENT ON HORMONE RECEPTORS
CN107382941B (zh) * 2017-07-10 2020-05-08 石家庄学院 黄酮衍生物及其制备方法和应用
EP3654767A1 (en) * 2017-07-18 2020-05-27 PVAC Medical Technologies Ltd. Anti-bacterial substance and composition thereof, medical and non-medical uses using the same, and products comprising said substance and compositions
CN109280067B (zh) * 2017-07-21 2022-07-05 南京正大天晴制药有限公司 香叶木苷衍生物、其制备方法以及医药用途
CN107550902A (zh) * 2017-10-31 2018-01-09 上海华堇生物技术有限责任公司 黄颜木素的药物用途
CN108752378A (zh) * 2018-07-12 2018-11-06 四川福思达生物技术开发有限责任公司 一种甲基次磷酸单烷基酯的合成方法
CN108997426B (zh) * 2018-07-19 2020-11-13 大连理工大学 靶向Hsp60的黄酮烷氧基氨基磷酸酯衍生物、制备及应用
CN114656579A (zh) * 2020-12-22 2022-06-24 安庆北化大科技园有限公司 一种低毒的黄酮醇磺酸酯类光引发剂及可见光引发体系和应用
CN113045527B (zh) * 2021-03-22 2022-11-08 广东省科学院动物研究所 二氢色原酮衍生物及其合成方法和用途
CN113321633B (zh) * 2021-05-21 2022-03-15 湖北工业大学 槲皮素-3-o-乙酸-(3-氯-4-硫代氨基)-苯酯及在制备糖尿病药物中的应用
CN115504970B (zh) * 2022-10-18 2023-04-18 黑龙江中医药大学 一种用于治疗心肌缺血的黄酮类衍生物及其制备方法

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US650846A (en) * 1899-05-10 1900-06-05 Heiman H Levy Branding-machine.
US3509026A (en) * 1967-01-19 1970-04-28 Litton Systems Inc Method of and apparatus for indicating the sensitivity of microorganisms to antibiotics
GB1461777A (en) * 1973-06-08 1977-01-19 Fisons Ltd 2-phenyl-4-oxo-4h-1-benzopyran derivatives
CA1309672C (en) * 1983-01-27 1992-11-03 Jannis G. Stavrianopoulos Methods and structures employing non-radioactive chemically-labeled polynucleotide probes
DE3442639A1 (de) * 1984-11-22 1986-05-22 Dr. Madaus & Co, 5000 Köln Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten
US5070018A (en) 1986-11-07 1991-12-03 The Board Of Trustees Of The Leland Stanford Junior University Method of controlling gene expression
JPH01153695A (ja) * 1987-12-11 1989-06-15 Showa Denko Kk ルチンまたはケルセチンリン酸エステルの製造法
JPH01308476A (ja) * 1988-06-06 1989-12-13 Showa Denko Kk 紫外線吸収剤
GB8926715D0 (en) 1989-11-28 1990-01-17 Haessle Ab Improvements relating to the administration of pharmaceutical agents
DE4134384A1 (de) 1991-10-17 1993-04-22 Ruetgerswerke Ag Modifizierte huminate, verfahren zu ihrer herstellung und verwendung
IL112764A0 (en) * 1994-03-18 1995-05-26 Ferrer Int New chromene derivatives
FR2719467B1 (fr) 1994-05-05 1996-05-31 Oreal Utilisation de flavonoïdes pour préserver et/ou renforcer les propriétés mécaniques des cheveux et procédé de protection des cheveux utilisant ces composés.
WO1996021440A1 (en) * 1995-01-09 1996-07-18 Alpha-Therapeutics, Inc. Methods for increasing the bioavailability of biological active agents
US6506792B1 (en) * 1997-03-04 2003-01-14 Sterix Limited Compounds that inhibit oestrone sulphatase and/or aromatase and methods for making and using
US6921776B1 (en) 1996-02-16 2005-07-26 Sterix Limited Compound
FR2764889B1 (fr) * 1997-06-20 2000-09-01 Sod Conseils Rech Applic Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
US6180661B1 (en) 1997-04-28 2001-01-30 Marigen, S.A. Bioflavonol-glycoside peresters and their incorporation into pharmacologically active concentrates and ultramicroemulsions
US5972995A (en) 1997-10-16 1999-10-26 Children's Hospital Medical Center Of Northern California Compositions and methods for cystic fibrosis therapy
FR2778663B1 (fr) 1998-05-15 2001-05-18 Coletica Nouveaux esters de flavonoides,leur utilisation en cosmetique, dermopharmacie, en pharmacie et en agro-alimentaire
AU8627798A (en) 1998-06-18 2000-01-05 Consiglio Nazionale Delle Ricerche Biocatalytic process for the preparation of 3-0-acyl-flavonoids
US6500846B1 (en) 1998-09-01 2002-12-31 Lg Chemical, Ltd. CDK inhibitors having flavone structure
CN1327384A (zh) 1998-10-20 2001-12-19 韩国科学技术研究院 作为血浆高密度脂蛋白浓度增高剂的生物类黄酮
JP2002535410A (ja) 1999-01-27 2002-10-22 ザィエリンスキ，ラブラトリー 高められたバイオアベイラビリティーを有するヘスペレチンプロフォーム
EP1055408A1 (de) 1999-05-26 2000-11-29 Nutrinova Nutrition Specialties & Food Ingredients GmbH Sorbatkonservierte Mittel, Verfahren zu deren Herstellung und ihre Verwendung
US6555523B1 (en) 1999-07-08 2003-04-29 Patrick T. Prendergast Use of cirsiliol and derivatives to treat infections
WO2001021608A2 (en) * 1999-09-23 2001-03-29 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Novel flavonoids
DE10003786A1 (de) 2000-01-28 2001-08-02 Merck Patent Gmbh Galenische Formulierung
EP1127572A3 (en) 2000-02-25 2003-05-02 Basf Aktiengesellschaft Use of flavones for treating cycloxygenase-2 mediated diseases
GB2348371B (en) 2000-03-14 2001-04-04 Soares Da Silva Patricio Compositions comprising blockers of L-DOPA renal cell transfer for the treatment of Parkinson's disease
EP1136073A1 (en) 2000-03-22 2001-09-26 N.V. Nutricia Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress
KR100833805B1 (ko) 2000-04-19 2008-05-30 니치유 가부시키가이샤 화장품 조성물
DE10031457C2 (de) 2000-06-28 2002-12-12 Jean Krutmann Verwendung von O-beta-Hydroxyethylrutosid oder dessen Aglycon zur systemischen Behandlung und Prophylaxe von UV-induzierten Dermatosen und unerwünschten Langzeitfolgen von UV-Bestrahlungen
JP2004505046A (ja) 2000-07-28 2004-02-19 イムファルム・アンパルトセルスカブ 感冒、アレルギー性鼻炎および気道に関連した感染症の症状の処置方法
DE10056400A1 (de) 2000-11-14 2002-05-23 Merck Patent Gmbh Galenische Formulierung
FR2820974B1 (fr) 2001-02-21 2004-02-13 Pharmascience Lab Composition topique comprenant une solution vraie contenant un derive de chromane ou de chromene, son procede de preparation et son utilisation cosmetique et therapeutique
JP3691764B2 (ja) 2001-03-07 2005-09-07 オリンパス株式会社 オートクレーブ装置
CA2445515A1 (en) 2001-05-04 2002-11-04 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
UY26816A1 (es) 2001-07-04 2003-04-30 Horacio Heinzen Una preparación liposomal de achyrocline satureioides ("marcela"), flavonoides y derivados semisintéticos, para la protección del tejido cerebral frente al dano isquémico- vascular y neurodegenerativo.
FI20011507A0 (fi) 2001-07-10 2001-07-10 Orion Corp Uusia yhdisteitä
ATE476178T1 (de) * 2001-09-06 2010-08-15 Synorx Inc Hemmung der t-lymphozyten-aktivierung durch 3- deoxyflavonoide und relevante therapien
ITRM20010600A1 (it) 2001-10-04 2003-04-04 Brane Tech S R L Composti flavonoidici capaci di modificare lo stato fisico e/o dinamico di membrane biologiche e di stimolare la sintesi endogena di protein
GB0125532D0 (en) * 2001-10-24 2001-12-12 Burton Michael Enzyme activity indicators
US20030125264A1 (en) 2001-12-29 2003-07-03 Kimberly-Clark Worldwide, Inc. Methods For Treating Wounds
US20050032882A1 (en) 2002-03-06 2005-02-10 Sophie Chen Botanical extract compositions and methods of use
US8945518B2 (en) 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US20050215493A1 (en) 2002-05-01 2005-09-29 Masaki Miyake Calcium-containing tissue strengthening agents and use thereof
FR2841784B1 (fr) 2002-07-08 2007-03-02 Composition a base de derives de 1,3-diphenylprop-2en-1-one substitues, preparation et utilisations
US20050080024A1 (en) 2002-08-15 2005-04-14 Joseph Tucker Nitric oxide donating derivatives for the treatment of cardiovascular disorders
US20050080021A1 (en) 2002-08-15 2005-04-14 Joseph Tucker Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
DE10244282A1 (de) 2002-09-23 2004-04-01 Merck Patent Gmbh Zubereitung mit antioxidanten Eigenschaften
AU2003263162B2 (en) 2002-10-24 2009-05-07 Immupharm A/S Pharmaceutical compositions comprising flavonoids and menthol
EP1591112A4 (en) 2003-02-04 2006-06-14 Yakult Honsha Kk INHIBITOR OF BREAST CANCER RESISTANT PROTEIN
US20050079235A1 (en) 2003-10-09 2005-04-14 Eggert Stockfleth Use of a polyphenol for the treatment of actinic keratosis
EP2292226A3 (en) 2003-10-09 2011-08-10 MediGene AG The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
US20070099826A1 (en) 2003-10-10 2007-05-03 Norman Wong Treatment of diseases associated with the egr-1 enhancer element
DE602005026276D1 (de) 2004-05-18 2011-03-24 Bright Future Pharmaceutical Lab Ltd Myricitrin verbindungen zur behandlung von schlafstörungen
WO2006004722A2 (en) 2004-06-30 2006-01-12 Biomol Research Laboratories, Inc. Compositions and methods for selectively activating human sirtuins
US20060105967A1 (en) 2004-11-18 2006-05-18 Advanced Gene Technology, Corp. Flavone derivatives as TNFalpha inhibitors or antagonists
NZ560633A (en) 2005-03-11 2011-08-26 Neuprotect Pty Ltd Flavonoid compounds and uses thereof
TWI282276B (en) 2005-04-12 2007-06-11 Univ Taipei Medical Pharmaceutical composition containing flavonoids which possess selective inhibition on phosphodiesterase 4 or 3/4
US20070037193A1 (en) 2005-08-12 2007-02-15 Rong-Hwa Lin Modulation of peroxisome proliferator-activated receptors
TW200735862A (en) 2006-01-06 2007-10-01 Abgenomics Corp Prostaglandin reductase inhibitors

Similar Documents

Publication Publication Date Title
JP2008532951A5 (ja)
USD565627S1 (en) Portion of an interface for a digital camera
JP2009039101A5 (ja)
CY2016040I1 (el) Επιλογες θεραπειας για τη νοσο του fabry
JP2008535798A5 (ja)
NO20091183L (no) Derivater av 4-(N-azacykloalkyl)-anilider, fremgangsmåte for fremstilling av slike forbindelser, preparater omfattende slike forbindelser samt anvendelse av slike forbindelser for forhindring eller behandling av sykdom
JP2004210767A5 (ja)
EP1888765A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS OF VENOUS THROMBOEMBOLIC ILLNESSES
EG25201A (en) 4-cyclopropyl-1,2,3- thiadiazole compound, agrohorticultural plant disease controlling agent and method of using the same
IL178390A0 (en) Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
BRPI0719849A2 (pt) Método de imunização contra os quatro sorotipos da dengue
WO2006078463A3 (en) Method for treating cardiovascular disease
AU2005339139A8 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
BRPI0718927A2 (pt) Método de imunização contra os quatro sorotipos da dengue.
WO2008070129A3 (en) Compositions and methods for the treatment of inflammatory disease
ATA11842004A (de) Impfstoff gegen die alzheimer-krankheit
IL192169A0 (en) Butylphthalide intravenous emulsion and application thereof
ITTO20060659A1 (it) Arresto di fondo corsa per una cerniera lampo, e cerniera lampo comprendente un tale arresto di fondo corsa.
JP2007308378A5 (ja)
NO20076405L (no) Anvendelse av 24-nor-UDCA
DE602006002608D1 (de) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
EP1896074A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CORONARY ARTERY DISEASE
ITBO20060237A1 (it) Metodo e macchina per l'incarto di articoli.
CL2007003315A1 (es) Composicion antimicrobiana sinergica que comprende un complejo de monoetanolamina-cobre (ii) y una 4,5-dicloro-2-n-octil-4-isotiazolin-3-ona.
JP2007169222A5 (ja)